Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 31
Biotech
Biotech | 14 August 2021

Bharat Biotech’s first nasal vaccine gets approval for Phase 2 trials

This is the first of its kind vaccine for Covid 19 to get the go-ahead

Biotech
Biotech | 14 August 2021

Indian Immunologicals receive manufacturing license for Covaxin drug substance

It falls under the Department of Biotechnology - Mission Covid Suraksha Project for augmenting manufacturing capacity for Covaxin

Biotech
Biotech | 13 August 2021

Study shows Moderna vaccine maintains antibodies against Variants of Concern and Interest

Studies include Alpha, Beta, Gamma, Delta, Epsilon and Iota and it maintains antibodies for six months after the second dose

Biotech
Biotech | 13 August 2021

Syngene sets up microbial facility as it expands biopharma-manufacturing capacity

It strengthens Syngene’s portfolio as a fully integrated custom biomanufacturer with added mammalian and microbial capabilities for clinical and commercial supplies

Biotech
Biotech | 12 August 2021

Global cell expansion market poised for huge growth

Asia-Pacific is projected to portray the fastest CAGR of 13.2 by 2030

Biotech
Biotech | 11 August 2021

Moderna to set up mRNA manufacturing in Canada

The collaboration will support Canada with direct access to rapid pandemic response capabilities

Biotech
Biotech | 11 August 2021

Penpulimab Monoclonal Antibody (PD-1) Obtains Marketing Approval in China

The approval is based on a multi-centre, single-arm, open-label pivotal clinical trial

Biotech
Biotech | 10 August 2021

Bayer strengthens drug discovery platform through acquisition of Vividion Therapeutics

Purchase price of US $ 1.5 billion upfront and up to USD 500 million in success-based milestone payments

Biotech
Biotech | 10 August 2021

INNOVIO QoQ revenues down for the period ended June 30, 2021

Company working on COVID vaccine INO 4800

Biotech
Biotech | 10 August 2021

Eagle Pharmaceuticals announces licensing agreement for Landiolol

Deal signed with AOP Orphan for US commercial rights

Biotech
Biotech | 10 August 2021

Atara Biotherapeutics, Pascal Touchon, Ameet Mallik, Rafael Holdings

A veteran in cell therapy and oncology commercialisation

Biotech
Biotech | 10 August 2021

Kite and Appia Bio collaborate to research and develop Allogeneic cell therapies for cancer

It leverages Kite’s Chimeric Antigen Receptors and Appia Bio’s Allogeneic Cell Technology Platform to Develop Off-the-Shelf Cell Therapies

Biotech
Biotech | 09 August 2021

Novavax announces COVID-19 vaccine booster data indicating four-fold increase in neutralising antibodies

Single booster dose at 6 months of NVX-CoV2373 increased wild-type neutralizing antibodies more than 4-fold versus primary vaccination series

Biotech
Biotech | 09 August 2021

AstraZeneca Pharma India PAT at Rs 10.24 crores

Board declares interim dividend of Rs 2 per equity share

Biotech
Biotech | 08 August 2021

Strides Pharma reports Q1FY22 consolidated loss at Rs 205.2 Cr

The company expects revenue growth of 10-15 per cent in the US

Biotech
Biotech | 08 August 2021

TAKE divests stake in Navitas Life Sciences to HIG

The transaction is expected to close in the Q4FY22

Biotech
Biotech | 07 August 2021

Sanofi to acquire Translate Bio

Advances deployment of mRNA technology across vaccines and therapeutics development

Biotech
Biotech | 06 August 2021

Mark W. Womack is the new CEO of Stelis Biopharma

He will be stationed at the company HQ in Bengaluru, India

Biotech
Biotech | 05 August 2021

Covaxin receives approval from Hungary

More countries recognise Covaxin

Startup

Digitization